SECONDARY IMMUNE THROMBOCYTOPENIA IN THE PRIMARY IMMUNODEFICIENCY DISORDER IN ADULT HEMATOLOGICAL PRACTICE

被引:0
作者
Melikyan, A. L. [1 ]
Egorova, E. K. [1 ]
Kalinina, M., V [1 ]
Pustovaya, E., I [1 ]
Kolosheynova, T., I [1 ]
Gilyazitdinova, E. A. [1 ]
Subortseva, I. N. [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow, Russia
来源
GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2017年 / 62卷 / 03期
关键词
secondary immune thrombocytopenia; primary immunodeficiency disorder; selective immunodeficiency of immunoglobulin A; X-LINKED AGAMMAGLOBULINEMIA; INTERNATIONAL-UNION; DISEASES; CLASSIFICATION; COMMITTEE; UPDATE;
D O I
10.18821/0234-5730-2017-62-3-159-163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombocytopenia is a symptom of a wide range of hematological and non-hematological diseases, requiring extensive diagnostic search. Rapid detection of the main cause of thrombocytopenia affects the prognosis and therapeutic tactics in a number of patients with hematological diseases. One of the reasons for the development of secondary thrombocytopenia are primary immunodeficiency disorders (PID), whose debut is possible at the age of over 18 years. Diagnosis of this pathology is difficult, due to the low alertness of primary care physicians about the presence of favorably occurring primary immunodeficiencies, the first manifestation of which can be the immune thrombocytopenia revealed in an adult. This article is devoted to the report of the clinical cases of newly diagnosed PID in adulthood, debuting from autoimmune complications.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 49 条
[41]   Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program [J].
Khellaf, Mehdi ;
Michel, Marc ;
Quittet, Philippe ;
Viallard, Jean-Francois ;
Alexis, Magda ;
Roudot-Thoraval, Francoise ;
Cheze, Stephane ;
Durand, Jean-Marc ;
Lefrere, Francois ;
Galicier, Lionel ;
Lambotte, Olivier ;
Panelatti, Gerard ;
Slama, Borhane ;
Damaj, Gandhi ;
Sebahoun, Gerard ;
Gyan, Emmanuel ;
Delbrel, Xavier ;
Dhedin, Nathalie ;
Royer, Bruno ;
Schleinitz, Nicolas ;
Rossi, Jean-Francois ;
Mahevas, Matthieu ;
Languille, Laetitia ;
Bierling, Philippe ;
Godeau, Bertrand .
BLOOD, 2011, 118 (16) :4338-4345
[42]   A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention [J].
Nowakowski, Andrzej ;
Arbyn, Marc ;
Turkot, Maryla H. ;
Wieszczy, Paulina ;
Milosz, Kinga ;
Kaminski, Michal F. ;
Didkowska, Joanna ;
Bidzinski, Mariusz ;
Olszewski, Wlodzimierz ;
Wielgos, Miroslaw ;
Krzakowski, Maciej ;
Kuchar, Ernest ;
Walewski, Jan .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (02) :157-164
[43]   Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency [J].
Martin, A. ;
Lavoie, L. ;
Goetghebeur, M. ;
Schellenberg, R. .
TRANSFUSION MEDICINE, 2013, 23 (01) :55-60
[44]   EVALUATION OF AGE-RELATED DISTRIBUTION OF MEASLES CASES WITH PRIMARY AND SECONDARY IMMUNE RESPONSE IN RUSSIAN FEDERATION, 2010-2016 [J].
Mamaeva, T. A. ;
Zheleznova, N., V ;
Bichurina, M. A. ;
Naumova, M. A. ;
Govorukhina, M., V ;
Toptygina, A. P. .
INFEKTSIYA I IMMUNITET, 2020, 10 (04) :717-728
[45]   Severity Outcomes among Adult Patients with Primary Immunodeficiency and COVID-19 Seen in Emergency Departments, United States, April 2020-August 2021 [J].
Drzymalla, Emily ;
Moonesinghe, Ramal ;
Kolor, Katherine ;
Khoury, Muin J. ;
Schieber, Lyna ;
Gundlapalli, Adi V. .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
[46]   A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID-19 pandemic [J].
Boyle, Therese ;
Zaragoza, Reina ;
Li, Jamma ;
Cvetanovski, Vera ;
Weaver, Phillippa ;
Hoyle, Philip ;
Venkatesha, Venkatesha ;
Fernando, Suran L. L. .
INTERNAL MEDICINE JOURNAL, 2023, 53 (07) :1256-1260
[47]   Why Is Rosacea Considered to Be an Inflammatory Disorder? The Primary Role, Clinical Relevance, and Therapeutic Correlations of Abnormal Innate Immune Response in Rosacea-Prone Skin [J].
Del Rosso, James Q. ;
Gallo, Richard L. ;
Kircik, Leon ;
Thiboutot, Diane ;
Baldwin, Hilary E. ;
Cohen, David .
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (06) :694-700
[48]   Retrospective Analysis of Autoimmune Diseases and Immunologic Characteristics of the Adult Primary Immune Deficiency Cohort: 17 Years Experience of the Tertiary Referral Immunology Center in Turkey [J].
Dalgic, Ceyda Tunakan ;
Sin, Aytul Zerrin ;
Ardeniz, Fatma Omar .
ASTIM ALLERJI IMMUNOLOJI, 2021, 19 (01) :12-23
[49]   A multicentre, prospective, non-randomized, sequential, open-label trial to demonstrate the bioequivalence between intravenous immunoglobulin new generation (IGNG) and standard IV immunoglobulin (IVIG) in adult patients with primary immunodeficiency (PID) [J].
Viallard, J. -F. ;
Brion, J. -P. ;
Malphettes, M. ;
Durieu, I. ;
Gardernbas, M. ;
Schleinitz, N. ;
Hoarau, C. ;
Lazaro, E. ;
Puget, S. .
REVUE DE MEDECINE INTERNE, 2017, 38 (09) :578-584